ID 4064 - Gorzknik kanadyjski

PL: Gorzknik kanadyjski
EN: Hydrastis canadensis(Common Name : Golden seal)
Pdf:

Oświadczenie (2)

1.4. Zmniejszenie ilości potencjalnie patogennych mikroorganizmów przewodu pokarmowego (ID 2362, 2730, 4064)

The claimed effects are “body's defence system against microorganism” and “immune health”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings, the Panel assumes that the claimed effects refer to the defence or resistance against harmful microorganisms.
The Panel considers that decreasing potentially pathogenic gastro-intestinal microorganisms might be a beneficial physiological effect.

2.1. Zmniejszenie ilości potencjalnie patogennych mikroorganizmów przewodu pokarmowego (ID 2362, 2730, 4064)

No human studies have been provided that investigated the effects of the food(s)/food constituent(s) that are the subject of the health claims on outcomes related to decreasing potentially pathogenic gastro-intestinal microorganisms.
The references provided included original articles, general review articles, book chapters, guides, web sites, monographs and reports. Of these references, many were not related to the food(s)/food constituent(s) which are the subject of the health claims but to a combination of ingredients, or they addressed effects not related to the health claim (e.g. cardiovascular effects, inhibition of human cytochrome P450), or they addressed phytotherapy and general medical uses of plants. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claimed effect.
An animal study provided for ID 4064 was focused on the effects of the food/food constituent on antigen-specific immunoglobulin production in rats injected with a novel antigen and then re-exposed. The Panel notes that the outcome studied was not related to the claimed effect and that no conclusions can be drawn from this reference for the scientific substantiation of the claimed effect.
A number of in vitro studies were provided related to the evaluation of the inhibitory activity and the antimicrobial mode of action of the food(s)/food constituent(s) that are the subject of the health claims on potentially pathogenic yeast, fungi, and bacteria. The Panel considers that while effects shown in in vitro studies may be used as supportive evidence, human studies are required for the substantiation of a claim, and that the evidence provided in in vitro studies alone is not sufficient to predict the occurrence of an effect of the consumption of the food(s)/food constituent(s) on decreasing potentially pathogenic gastro-intestinal microorganisms.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the food(s)/constituent(s) which are the subject of the health claims and decreasing potentially pathogenic gastro-intestinal microorganisms.

Warunki i możliwe ograniczenia stosowania oświadczenia

Root / The equivalent of 1500-3000mg of root